Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Hammerschmidt

JAMA

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
JAMA|November 14, 1980
Of lungs and leukocytesD E Hammerschmidt
JAMA|January 15, 1982
Platelets and the environmentD E Hammerschmidt
JAMA|July 3, 1981
The scientific mind at work (and play)H S Jacob, D E Hammerschmidt
JAMA|May 22, 1981
Complement-induced granulocyte aggregation. Importance in myocardial infarction and shock lungH S Jacob, D E Hammerschmidt
JAMA|December 4, 1981
Ham's test in vivo?D E Hammerschmidt, P A Coppo, H S Jacob
JAMA|November 4, 1983
Fatal complement-induced leukostasis after diatrizoate injection. Principles of clinicopathologic diagnosisH Schneiderman, D E Hammerschmidt, A R McCall, et al.
JAMA|July 11, 1980
A new form of Ehlers-Danlos syndrome. Fibronectin corrects defective platelet functionM A Arneson, D E Hammerschmidt, L T Furcht, et al.
JAMA|May 1, 1987
Leukocytes and the risk of ischemic diseasesE Ernst, D E Hammerschmidt, U Bagge, et al.
JAMA|March 12, 1982
Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation. A possible mechanism for its efficacy in bacteremic shockR J Xiu, D E Hammerschmidt, P A Coppo, et al.
JAMA|November 19, 1982
Maternal Ehlers-Danlos syndrome type X. Successful management of pregnancy and parturitionD E Hammerschmidt, M A Arneson, S L Larson, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
JAMA|November 14, 1980
Of lungs and leukocytesD E Hammerschmidt
JAMA|January 15, 1982
Platelets and the environmentD E Hammerschmidt
JAMA|July 3, 1981
The scientific mind at work (and play)H S Jacob, D E Hammerschmidt
JAMA|May 22, 1981
Complement-induced granulocyte aggregation. Importance in myocardial infarction and shock lungH S Jacob, D E Hammerschmidt
JAMA|December 4, 1981
Ham's test in vivo?D E Hammerschmidt, P A Coppo, H S Jacob
JAMA|November 4, 1983
Fatal complement-induced leukostasis after diatrizoate injection. Principles of clinicopathologic diagnosisH Schneiderman, D E Hammerschmidt, A R McCall, et al.
JAMA|July 11, 1980
A new form of Ehlers-Danlos syndrome. Fibronectin corrects defective platelet functionM A Arneson, D E Hammerschmidt, L T Furcht, et al.
JAMA|May 1, 1987
Leukocytes and the risk of ischemic diseasesE Ernst, D E Hammerschmidt, U Bagge, et al.
JAMA|March 12, 1982
Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation. A possible mechanism for its efficacy in bacteremic shockR J Xiu, D E Hammerschmidt, P A Coppo, et al.
JAMA|November 19, 1982
Maternal Ehlers-Danlos syndrome type X. Successful management of pregnancy and parturitionD E Hammerschmidt, M A Arneson, S L Larson, et al.
Pageof 2